Evidence map›Paper›PMID 31645653›Full record

ArticleJournal of human genetics2020

De novo ZBTB7A variant in a patient with macrocephaly, intellectual disability, and sleep apnea: implications for the phenotypic development in 19p13.3 microdeletions.

Akira Ohishi, Yohei Masunaga, Shigeo Iijima, Kaori Yamoto, Fumiko Kato, Maki Fukami, Hirotomo Saitsu, Tsutomu Ogata

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. AI platform for CRISPR functional mapping and function-based drug design.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. [Cardiofaciocutaneous syndrome caused by microdeletion of chromosome 19p13.3: a case report and literature review].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Akira OhishiMaternal-Fetal and Neonatal Care Center, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Yohei MasunagaDepartment of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Shigeo IijimaMaternal-Fetal and Neonatal Care Center, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Kaori YamotoDepartment of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Fumiko KatoDepartment of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Maki FukamiDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.ORCID http://orcid.org/0000-0001-9971-4035
Hirotomo SaitsuDepartment of Biochemistry, Hamamatsu University school of Medicine, Hamamatsu, Japan.ORCID http://orcid.org/0000-0003-0723-0960
Tsutomu OgataDepartment of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan. tomogata@hama-med.ac.jp.ORCID http://orcid.org/0000-0001-7178-9991
Hamamatsu University School of Medicine · JPHamamatsu University · JPNational Center For Child Health and Development · JP

Funding

Japan Agency for Medical Research and Development (AMED) 19ek0109278Japan Agency for Medical Research and Development (AMED) JP18ek0109301Japan Agency for Medical Research and Development (AMED) JP19ek0109297
6 · The paper itself

Abstract

Interstitial microdeletions at chromosome 19p13.3 are frequently associated with a constellation of clinical features including macrocephaly, characteristic face, intellectual disability, and sleep apnea. Previous studies in 25 patients with 19p13.3 microdeletions have revealed loss of MAP2K2 in 24 patients and that of PIAS4 and ZBTB7A in 23 patients, suggesting that these three adjacent genes are candidate genes for the phenotypic development in 19p13.3 microdeletions. We identified a de novo likely pathogenic heterozygous missense variant of ZBTB7A (NM_015898.3:c.1152C>G, p.(Cys384Trp)) in a Japanese boy with macrocephaly, intellectual disability, and sleep apnea. This variant affects the conserved cysteine residue forming the coordinate bond with Zn

Indexed as

Abnormalities, MultipleChildChromosome DeletionChromosomes, Human, Pair 19DNA-Binding ProteinsHeterozygoteHumansIntellectual DisabilityMaleMAP Kinase Kinase 2MegalencephalyMutation, MissensePhenotypeSleep Apnea SyndromesTranscription FactorsDNA-Binding ProteinsMAP2K2 protein, humanMAP Kinase Kinase 2Transcription FactorsZBTB7A protein, human

Identifiers

PMID31645653
OpenAlexW2981448482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.